-
Severe sepsis affects 500,000 annually in the United States
-
Despite improvements in critical care mortality of 20-50% remains unchanged
Definitions
| Condition |
Definition |
| Bacteraemia |
The presence of viable bacteria in the bloodstream |
| SIRS |
The systemic inflammatory response to a variety of clinical
insults manifest by two or more of the following:
- Temperature >38°C
or <36°
- Heart Rate > 90 bpm
- Respiratory Rate > 20 breaths per minute or PaCO2 > 4.3 kPa White Cell Count > 12,000 or
<4,000 per mm3
|
| Sepsis |
SIRS with documented infection |
| Severe SIRS |
SIRS with documented infection and hypoperfusion, hypotension and
organ dysfunction |
| Septic Shock |
Sepsis with hypotension despite adequate fluid resuscitation |
Clinical features of sepsis and SIRS
- Cardiorespiratory effects
- Increased cardiac output
- Decreased vascular resistance
- Increased oxygen consumption
- Fever or hypothermia
- Tachycardia
- Tachypnoea
- Metabolic or haematological effects
- Respiratory alkalosis
- Deranged liver function
- Deranged renal function
- Altered whit cell count and platelets
- Disseminated intravascular coagulation
Aetiology of SIRS
SIRS can arise from a number of aetiological triggers
- Infection – bacterial, viral, fungal
- Hypovolaemic shock
- Trauma
- Burns
- Tissue ischaemia
- Pancreatitis
Bacterial Infection is commonest cause
- 50% due to gram-negative organisms
- 40% due to gram-positive organisms
Mechanisms in the pathology of SIRS
- Over-production of inflammatory mediators
- Under-production of anti-inflammatory mediators
- Receptor abnormalities
- Decreased destruction of inflammatory mediators
- Abnormal leukocytes
Major inflammatory mediators involved in SIRS
- Platelet activating factor
- Tumour necrosis factor -alpha
- Interleukin-1
- Interleukin-6
- Interleukin-8
- Interleukin-10
Bibliography
Boontham P, Chandran P, Rowlands B, Eremin O. Surgical sepsis: dysregulation of
immune function and therapeutic implications. Surg J R Coll Surg Edinb Irel 2003; 1:
187-206.
Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
Parker S J, Watkins P E. Immunomodulatory therapies of sepsis and SIRS. In: Johnson C
D, Taylor I eds. Recent advances in surgery 23. Edinburgh, Churchill Livingston 2000:
55-68.
Paterson R L, Webster N R. Sepsis and the systemic inflammatory response syndrome. J R Coll
Surg Ed 2000; 45: 178-182.
Vincent J L, de Carvalho F B, de Backer D. Management of septic shock. Ann Med
2002; 34: 606-613.
Wheeler A P, Bernard G R. Treating
patients with severe sepsis. N
Eng J Med 1999; 340: 207-214.
|